NYSCF in the News
NYSCF partnered with the American Museum of Natural History in New York on their learning exhibition “The Science of Stem Cells in the Sackler Educational Laboratory.” This exhibition explores the basic biology of stem cells and what promise they hold for future treatments and includes live animals and specimes for exploration.
 
The NYSCF Research Institute provided live stem cell samples, including beating heart cells, for viewing and sparking conversation amongst museum attendees.
 
This exciting learning opportunity is free with museum membership or admission and is open for two more weekends, October 1-2 and October 8-9.  
 
 
Misunderstanding and misrepresentation of science in the media is a pervasive and age-old problem for research institutions. David McKeon, NYSCF Chief of Staff, explored this important issue and shared the steps NYSCF takes to correct false media representation of our work at the annual Health Research Alliance (HRA) Conference in Bethesda, Maryland. 
 
Mr. McKeon discussed NYSCF’s strategies for clearly communicating our work and working with the media to accurately describe the science. He provided case studies using NYSCF’s discoveries, and the actions he and his colleagues take to prevent distortion of the science in the media. 
 
HRA is an organization that fosters collaboration among non profit and non-governmental funders to support health research and training to advance health. The annual conference brings together HRA members to share best practices and new ideas all with a goal of advancing health. 
 
 
The NYSCF Innovator Programs feature top scientists from around the world in their respective fields of study. Recognition of six NYSCF - Robertson Investigators as 2016 Faculty Scholars by the Howard Hughes Medical Institute, the Simons Foundation, and the Bill & Melinda Gates Foundation highlights the strength and quality of all of the NYSCF Innovator Programs. 
 
The Faculty Awards name early-career scientists who have great potential to make unique contributions to their field. Eighty-four scientists representing fourty-three institutions were selected for the awards in this inaugural program year. 
 
The NYSCF - Robertson Investigators who received the award are: 
  • Ed Boyden, PhD, MIT Media lab
  • Edward Chang, MD, University of California, San Francisco
  • Valentina Greco, PhD, Yale University
  • Jayaraj Rajagopal, MD, Massachusetts General Hospital
  • Marius Wernig, MD, PhD, Stanford University
  • Feng Zhang, PhD, Broad Institute of MIT and Harvard

 

Learn more about the 2016 Faculty Awards >>

Learn more about the NYSCF Innovator Programs >>

Tuesday, 27 September 2016 15:21

Explaining Schizophrenia with Multiple Genes

NYSCF – Robertson Stem Cell Investigator Dr. Kristen Brennand and her team at the Icahn School of Medicine at Mount Sinai published their latest research exploring the genetic risk of schizophrenia in Nature Neuroscience. The paper showed that schizophrenia is polygenic, meaning that multiple different genes are implicated in causing the disease as opposed to only one. 
 
In addition, the scientists' work highlighted the importance and utility of the CommonMind Consortium as a resource for gene expression and genetic regulation research, using the sequenced RNA from brain samples of over 500 people including patients with schizophrenia provided by the Consortium.
 
 
Tuesday, 27 September 2016 15:19

NYSCF University - What It Means To Me

Each year, NYSCF University, our ten-week summer internship program, gives top college students from around the world the opportunity to work in the NYSCF Research Institute laboratories with NYSCF scientists and engineers. This video features the students in the 2016 NYSCF University class sharing what this experience has meant to them in their own words.

 

Learn more about NYSCF University >>

Learn more about NYSCF Science Education Programs >>

Tuesday, 27 September 2016 15:07

NYSCF Talks in East Hampton and at Mount Sinai

NYSCF CEO Susan L. Solomon discussed NYSCF’s many roles in research and policy in two events this past month. 
 
The East Hampton Library invited Ms. Solomon to speak about “Cells and Souls: Frontiers in Stem Cell Research” as part of their 2016 Tom Twomey Lecture Series. The talk, hosted by Sheila Rogers, focused on how advanced stem cell research is ushering in the future of regenerative medicine including first steps towards personalized treatments. The Tom Twomey Series features guest lectures from people with a wide variety of backgrounds and runs from April to October annually. 
 
The second talk kicked off the Icahn School of Medicine at Mount Sinai science policy seminar series. Ms. Solomon discussed “Stem Cell Policy – Who Get’s to Decide?” and the role of the patient voice in scientific research. The talk focused on how and why Ms. Solomon started NYSCF in 2005, her role as a patient advocate, and how NYSCF has worked for changes in current stem cell policy and regulations.
 
 
 
 
 

NYSCF – Druckenmiller Fellow Dr. Hongda Li, The Rockefeller University, was first author on two papers investigating the zika virus. The first paper, published in Cell Stem Cell, described how zika may affect adult brain cells in addition to the mounting evidence that it causes abnormalities in the brains of developing fetuses. Using adult mouse models, the scientists showed that zika infects neural progenitor cells, cells thought to be critical in learning and memory. 

The second paper in The American Journal of Human Genetics identified genetic mutations linked to the mechanisms causing autosomal-recessive primary microcephaly, a genetic form of microencephaly. This research helps illuminate the specific genetic pathways leading to microencephaly, a devastating side effect of zika infection in utero.

 

Read more from The Rockefeller University >>

Read more in Infection Control Today >>

Read the paper in Cell Stem Cell >>

Read the paper in The American Journal of Human Genetics >>

NYSCF – Robertson Investigator Alumna Dr. Shuibing Chen published her latest work in Cell Stem Cell creating stem cell models of type 2 diabetes in a step towards applying knowledge from genome-wide association studies to drug discovery efforts. Dr. Chen and her team at Weill Cornell Medical College created human stem cell models with genetic mutations in genes associated with the development of type 2 diabetes as identified through genome-wide association studies. 

These stem cell models allow scientists to further interrogate the genes in question without harming patients, paving the way for precision therapy for metabolic diseases including type 2 diabetes.

 

Read the paper in Cell Stem Cell >>

Page 1 of 28
You are here: News NYSCF in the News